5 Results for "

LacK free acid

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "LacK free acid" in MCE Product Catalog:

Cat. No.: HY-W883690
CAS No.: 1227379-69-2
Target:  

Endogenous Metabolite

Research Areas:  

Others

LacK (free acid) is a lysine derivative used in lactate acylation studies .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-136093B
CAS No.: 1422365-93-2
Synonyms: IM156 free base; HL156A free base; HL271 free base
Lixumistat (IM156 free base) is a potent and orally active AMPK activator and OXPHOS inhibitor. Lixumistat strongly activates AMPK, while it lacks the systemic metabolic regulatory effects of classic metformin, such as hypoglycemic and weight-lowering activities. Lixumistat exhibits significant therapeutic effects on cognitive decline associated with brain aging and pulmonary fibrosis .
loading...
    loading...
Cat. No.: HY-125604A
CAS No.: 1706523-58-1
Research Areas:  

Infection Inflammation/Immunology

WCK-4234 free base is a diazabicyclooctane β-lactamase inhibitor and susceptibility restorer. WCK-4234 free base lacks direct antibacterial activity. WCK-4234 free base inhibits class A, C, D β-lactamases and extended-spectrum β-lactamases to potentiate Imipenem (HY-B1369A) and Meropenem (HY-13678) activity against Gram-negative pathogens. WCK-4234 free base can be used for the research of gram-negative bacterial infections and β-lactamase-mediated carbapenem-resistant bacterial infections .
loading...
    loading...
Cat. No.: HY-187344
GLP-1R prodrug-1 is a GLP-1R agonist prodrug. GLP-1R prodrug-1 lacks direct GLP-1R agonistic activity. GLP-1R prodrug-1 is slowly converted into its active free acid metabolite GLP-1R agonist 45 (HY-187343) in plasma via esterase-mediated hydrolysis. GLP-1R prodrug-1 can be used in the research of type 2 diabetes and obesity .
loading...
    loading...
Cat. No.: HY-N20734
CAS No.: 64527-08-8
Synonyms: Polygalacin
Rhamnazin 3-O-rutinoside (Polygalacin) is a flavonoid compound. Rhamnazin 3-O-rutinoside can be extracted from Areca catechu L. Rhamnazin 3-O-rutinoside shows no significant inhibitory effect on recombinant hPTP1B, with an IC50 > 100 μM. Rhamnazin 3-O-rutinoside reduces Apoptotic cell death. Rhamnazin 3-O-rutinoside possesses cellular antioxidant activity and alleviates H2O2-induced oxidative stress. Rhamnazin 3-O-rutinoside lacks free radical scavenging activity. Rhamnazin 3-O-rutinoside can be used in the research of neurodegenerative diseases .
loading...
    loading...